The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNEL.L Regulatory News (CNEL)

  • There is currently no data for CNEL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Yearly Report

27 Sep 2013 13:11

RNS Number : 1288P
China New Energy Ltd
27 September 2013
 



27 September 2013

 

China New Energy Limited

("China New Energy" "CNE" or "the Group")

 

 

Half-yearly report for the six months to 30 June 2013

 

China New Energy Limited (AIM: CNEL), the engineering and technology solutions provider to the bioenergy sector, announces its unaudited half-yearly results for the six months ended 30 June 2013.

 

Financial Highlights

· Revenue of RMB 20.1m (H1 2012: RMB 48.7m)

· Gross profit of RMB 2.67m (H1 2012: RMB 6.30m)

· Net loss of RMB 5.39m (H1 2012: loss of RMB 6.04m)

· Loss per share of RMB 0.0097 (H1 2012: RMB 0.019)

 

Operational Highlights

· Thailand UBBE project was transferred to owner and is now operating successfully

· LOI with Nigeria's Federal Ministry of Agriculture and Rural Development ("FMARD") to build 10 biorefineries in Nigeria

 

 

Yu Weijun, Chairman, commented:

 

"As previously commented, historically we usually make a loss in the first half of the year as most projects are completed and paid for in the second half of the year. This financial year, CNE also invested considerable effort into completing the biorefinery project in Thailand and handing over the operations to our customer UBBE. I am proud of our achievement and this flagship project will serve as a reference site that we expect will help us secure new international contracts during the current financial year.

 

Looking ahead, we remain confident that low-carbon biofuel will be a clear alternative to fossil fuel and growth will return to the bioenergy sector. We continue to look to the long-term future with confidence."

 

Enquiries:

 

China New Energy Limited

www.chinanewenergy.co.uk

Richard Bennett

Tel: +44 (0)20 7148 3148 or rbennett@zkty.com.cn

Ivy Xu

Tel: +86 (0)20 8705 9371 or xuhj@zkty.com.cn

Cairn Financial Advisers LLP (NOMAD)

Tel: +44 20 7148 7900

Jo Turner / Liam Murray

SVS Securities plc (Broker)

Tel: +44 20 7638 5600

Alexander Brearley

Chairman's Statement

 

On behalf of the Board, I am very pleased to present the unaudited half-yearly results for the six months period ended 30 June 2013.

 

Financial Review

 

Revenue for the first six months of the year was down to RMB 20.1m (H1 2012:RMB 48.7m) and the Group's gross profit was down to RMB 2.67m (H1 2012:RMB 6.3m).However the Net loss was also reduced to RMB 5.4m(H1 2012: RMB 6.04m). Due the cyclical nature of our business, historically we usually make a loss in the first half of the year as most projects are completed and paid for in the second half of the year.

 

The first half of the year was challenging for the Group's core EPC (Equipment, Procurement and Construction) business. This is mainly due to the continued depressed ethanol price and lower demand for ethanol related products during the period, which in-turn continues to delay the capital expenditure of ethanol producers.

 

Selling and distribution expenses rose by23.2% to RMB1.89m (H1 2012:RMB1.54m) while administrative expenses decreased by 37.6% to RMB 5.2m (H1 2012:RMB 8.3m) as no incentives were granted to employees through the company's Employee Benefit Trust. The Group's other operating expenses were up to RMB 0.7m (H1 2012:RMB0.6m).Finance expense decreased by 49%to 0.4m (H1 2012:0.8m) due to reduced debt.

 

 

Operational Review

In H12013, the Group secured several small contracts for its products and services in China and Burma. The total contracted amount is RMB 19.1 million.

 

During the period, CNE invested considerable effort into completing the biorefinery project in Thailand and handing over the operations to our customer UBBE. The successful completion of their project is a testament to the Group's ability to design and construct high quality cassava or molasses based ethanol production facilities. The Board believes that the Group's customers consider the Group to be a reliable and suitable development partner and the Group is currently negotiating to provide further products and services to construct additional auxiliary facilities for UBBE.

 

We believe our success in completing thisproject will act as a reference and will strongly position the Group to capture market share in South East Asia and Africa where there is abundance of inexpensive cassava feedstock.

 

During the period, with our development partner Sunbird Bioenergy, the Groupsigned a letter of intent with Nigeria's Federal Ministry of Agriculture and Rural Development ("FMARD") to expand agricultural investment and operations in Nigeria to build 10 biorefineries in the country. Nigeria has committed to the World Economic Forum (WEF) that it will implement an Agricultural Transformation Agenda and create a new domestic farming industry, and cassava will be one of the primary products. CNE's experience and reference project in Thailand enabled us to demonstrate to FMARD that we have the skills to develop a cassava-value chain that will produce profitable bioethanol from cassava. The Group continues to negotiate binding contracts in Nigeria and looks forward to updating shareholders in due course.

 

 

Outlook

 

After the recent volatility in the global financial markets and the bioethanol market downturn, there is a risk that the Group may continue to face difficult trading conditions and as a result the Board maintains its cautious business approach. Nevertheless, the Board remains positive about the Group's prospects and outlook in the biofuel industry.

 

It remains a priority for management to identify new lines of business with recurring income and during the period the Group has conducted due diligence on a number of potential acquisitions that meet this criteria. Whilst no transaction has currently been concluded, the Board will continue to seek substantial M&A opportunities that have the potential to deliver recurring income and stable cash flows.

 

China is an important participant in global energy markets. In the interests of its energy security, the PRC government has enacted various laws and regulations encouraging the use of renewable energy as a substitute for fossil fuels. Bioenergy is widely considered to be one of the key alternatives to fossil fuel use because of its easy acquisition and cleaner emissions. Our strategy is to craft core competence in the provision of a full spectrum of engineering technology for the renewable fuel and chemicals sector. We strive to provide superior technology and engineering solutions from feedstock conversion to end waste management for the bioenergy and biochemical sectors, enabling producers in these sectors to achieve environmentally friendlier products with improving operating margins.

 

The global recession, especially in the U.S. and Europe, may further impede the available resources for research and development activities in our industry. The Group, however, intends to continue to channel its own resources into biofuel production research and development by relying on our qualified staff and by collaborating with external institutions to carry out further research and development activities. Our collaboration partners include Guangzhou Institute of Energy Conversion ("GIEC"), part of the Chinese Academy of Sciences. GIEC is a leading research institute in the PRC that specialises in the research of alternative and renewable energy technologies. We believe our close long term working relationship with GIEC can help to commercialise our R&D much faster and at a lower cost.

 

The Directors and management team are confident in the Group's outlook and are determined to position the Group for growth. To strengthen our market position and to add value to our existing business, the Group is also actively exploring opportunities to expand into complementary businesses or operations through acquisitions, joint ventures or strategic alliances.

 

While the Board maintains its cautious approach in view of the current global macro-economic conditions and a slowdown in demand for ethanol, the Group also continues to explore opportunities and negotiate new projects in the PRC and overseas with prospective customers.

 

 

Yu Weijun

Chairman

 

27 September 2013Consolidated Statement of Financial Position

Unaudited

Unaudited

Audited

Six months to 30 June

Six months to 30 June

Year to 31 December

2013

2012

2012

Note

RMB'000

RMB'000

RMB'000

Non-current assets

Property, plant and equipment

9,841

9,208

11,245

Intangible assets

4,935

4,649

4,760

Trade receivables

3,523

3,523

3,523

Investments in subsidiaries

30,950

1,700

30,950

49,249

19,080

50,478

Current assets

Inventories

8,564

27,118

12,286

Due from customers for construction contracts

89,769

74,598

86,832

Financial asset at fair value through profit and loss

160

Trade and other receivables

54,762

68,825

50,429

Notes receivables

800

-

7,600

Cash and cash equivalents

10,965

3,592

11,310

164,860

174,293

168,457

Current liabilities

Trade and other payables

92,734

82,306

95,901

Due to customers for construction contracts

12,298

19,404

10,525

Notes payables

500

2,427

5,404

Income tax payable

8,796

4,460

9,020

Short-term borrowing

6,600

6,500

Interest payable

2,325

Convertible bonds

23,318

30,252

25,081

144,246

147,674

145,931

Net current (liabilities)/assets

20,614

26,619

22,525

Non-current liabilities

Deferred tax liabilities

815

909

859

815

909

859

Net (liabilities)/assets

69,048

44,790

72,145

Equity and reserves

Ordinary Share

2

1,134

1,118

1,134

Share premium

39,171

38,601

39,171

Combination reserve

(33,156)

(33,156)

(33,156)

Warrants reserve

1,673

1,673

1,673

Statutory reserve

12,328

9,856

12,328

Convertible bonds reserve

6,549

6,549

6,549

Own shares

(5,853)

(5,853)

(5,853)

Accumulated earnings/(losses)

22,567

2,636

27,954

Foreign currency translation reserve

24,635

23,366

22,345

69,048

44,790

72,145

 

 

 

Consolidated Statement of Comprehensive Income

 

Unaudited

Unaudited

Audited

Six months to 30 June 2013

Six months to 30 June 2012

Year to 31 December 2012

Note

RMB'000

RMB'000

RMB'000

Revenue

20,158

48,693

146,154

Cost of sales

(17,494)

(42,390)

(120,177)

 

 

 

Gross profit

2,664

6,303

25,977

Other operating income

102

322

24,435

Investment Income

(1,427)

Selling and distribution expenses

(1,891)

(1,535)

(3,394)

Administrative expenses

(5,153)

(8,261)

(16,922)

Other operating expenses

(721)

(609)

(1,490)

Finance expenses

(432)

(848)

(2,359)

Change in fair value of held for sale investments

13

 

 

 

Profit/(loss) before income tax

(5,431)

(6,043)

26,247

Income tax expense

44

4

(4,495)

 

 

 

Profit/(loss) for the financial period

(5,387)

(6,038)

21,752

Other comprehensive income:

Exchange difference

2,290

(327)

1,348

(3,097)

(6,365)

20,404

Total comprehensive income for the financial year

(3,097)

(6,365)

20,404

Total comprehensive income attributable to equity holder

Earnings/(loss) per share (RMB):

Basic

4

(0.0097)

(0.019)

0.070

Diluted

4

(0.0097)

(0.019)

0.068

 

 

Consolidated Statement of Cash flows

 

Unaudited

Unaudited

Audited

Six months to 30 June

Six months to 30 June

Year to 31 December

2013

2012

2012

RMB'000

RMB'000

RMB'000

Operating activities

Profit/(loss) before income tax

(5,431)

(6,042)

26,247

Adjustments for:

Depreciation and amortisation

1,096

986

2,104

Administrative expenses - issue of shares to employees

2,207

2,207

 

Bad debt written back

(19,105)

Loss/(gain) on disposal of property, plant and equipment

(242)

70

Loss/(gain) on disposal of financial assets

924

Fair value gain

Interest income

(119)

(269)

(394)

Finance expense

443

1,126

1,435

Impairment of investment

750

Operating cash flows before movements in working capital

(4,253)

(1,992)

14,238

Inventories

3,722

(3,763)

11,068

Construction work-in-progress

(1,164)

27,993

6,880

Trade and other receivables

(4,333)

(14,867)

(6,549)

Notes receivables

6,800

3,150

(4,450)

Trade and other payables

(3,167)

(10,382)

(4,900)

Notes payables

(2,562)

(2,298)

679

Deferred tax

 

 

 

Cash generated from/(used in) operations

(4,957)

(2,159)

16,966

Income taxes paid

(224)

(169)

(182)

Dividend received

 

 

 

Net cash from/(used in) operating activities

(5,181)

(2,328)

16,784

Investing activities

Proceeds from disposal of property, plant and equipment

6,257

Proceeds from trading financial assets

7,022

Acquisition of property, plant and equipment

(278)

(3,375)

Acquisition of intangible assets

(739)

Payment for associated company in the course of acquisition

Net cash from/(used in) investing activities

6,744

(2,143)

 

 

 

Financing activities

Short-term borrowing

6,600

 -

6,500

Proceeds from issuance of shares

 -

 -

586

Redemption of convertible bonds

 -

 -

-

interest received

 -

 -

-

Proceeds from issuance/ (redemption) of convertible bonds

(1,763)

 -

(8,171)

Redemption of bonds

(7,506)

 -

Interest received

119

 -

 -

394

Interest paid

(120)

-

-

(613)

Net cash from/(used in) financing activities

4,836

(7,506)

(14,304)

 

 

 

Net increase/(decrease) in cash and cash equivalents

(345)

(3,090)

4,623

Cash and bank balances at beginning of period

11,310

6,682

6,682

Effect of foreign exchange rate changes in cash and bank balances

-

-

5

Cash and cash equivalents at end of period

10,965

3,592

11,310

 

 

 

Consolidated Statement of Changes in Equity

Share capital

Share premium

Combination

Statutory reserve

Convertible bonds reserve

Warrants reserve

Own shares

Accumulated earnings/ (losses)

Foreign currency translation reserve

Total

RMB'000

RMB'000

RMB'000

RMB'000

RMB'000

RMB'000

RMB'000

RMB'000

Balance at 31 December 2011

1,118

38,601

-33,156

9,856

6,549

1,673

-5,853

6,467

 

23,693

48,948

Profit for the period

-

-

-

-

-

-

-

21,752

21,752

Exchange difference arising on the translation

-

-

-

-

-

-

-

 

-1,348

-1,348

Total comprehensive income for the period

-

-

-

-

-

-

-

21,752

-1,348

20,404

Issue of warrants

-

-

Issue of shares, net of share issue costs

16

570

-

586

Shares granted to Employee Benefit Trust

2,207

-

2,207

Transfer to statutory reserve

2472

-2,472

-

-

Balance at 31 December 2012

1,134

39,171

-33,156

12,328

6,549

1,673

-5,853

 

27,954

 

22,345

 

72,145

Profit for the period

-

-

-

-

-

-

-

-5,387

-5,387

Exchange difference arising on the translation

-

-

-

-

-

-

-

 

2,290

2,290

Total comprehensive income for the period

-

-

-

-

-

-

-

-5,387

2,290

-3,097

Issue of warrants

-

-

Issue of shares, net of share issue costs

-

-

-

-

Shares granted to Employee Benefit Trust

-

-

Transfer to statutory reserve

-

-

Balance at 30 June2013

1,134

39,171

-33,156

12,328

6,549

1,673

-5,853

 

22,567

 

24,635

 

69,048

  

Notes to the Interim Financial Information - Period ended 30 June 2013

 

1. Basis of preparation

 

The financial statements have been prepared in accordance with the International Financial Reporting Standards (IFRS) as adopted by the European Union. The principal accounting policies used in preparing the interim results are those the group expects to apply in its financial statements for the year ending 31 December 2013 and are unchanged from those disclosed in the group's Report and Financial Statements for the year ended 31 December 2012, except for the following additional accounting policies:

 

Basis of consolidation

The Group includes the assets and liabilities of the Employee Benefit Trust ("EBT") within its Statement of Financial Position. In the event of the winding up of the Group, neither the shareholders nor the creditors would be entitled to the assets of the EBT.

 

Long-term incentive scheme charge

The fair value of the employee services received in exchange for the grant of shares or share options is recognised as an expense.

 

The total amount to be expensed over the performance period, from grant date to vesting date, is determined by reference to the fair value of the shares determined at the date the employee is deemed to be fully aware of their potential entitlement and all conditions of vesting.

 

Own shares

Company shares held by the EBT are deducted from the shareholders' funds and classified as Own Shares until such time as they vest unconditionally to participating employees and their families.

 

This interim financial information has not been reviewed or audited by the Group's auditors. The comparatives for the period ended 31 December 2012 are not the Group's full statutory accounts for that period but have been extracted from those financial statements. A copy of the statutory financial statements for that period, which were prepared under IFRS, has been delivered to the Companies Registry. The auditors' report on those accounts was unqualified.

 

Whilst the financial information included in this Interim Financial information has been prepared in accordance with the recognition and measurement criteria of IFRS, it does not include sufficient information to comply with IFRS.

 

This interim report was approved by the Board of directors on 27 September 2013.

 

 

2. Ordinary shares

 

 

 Number of Shares

 Share Capital

 Share premium

 £ '000

 RMB '000

 £ '000

 RMB '000

 As at 31st December 2010

6,733,107

67

1,013

1,952

29,354

 As at 21st March 2011

67,331,070

67

1,013

1,952

29,354

 As at 6 May 2011

269,324,280

67

1,013

1,952

29,354

 Shares issued in connection with the Placing

9,360,147

2

24

653

6,756

 Share issued in settlement of fees to professional

9,920,295

2

26

692

7,160

 Share issued to EES Trustees International Limited

8,079,728

2

21

564

5,832

 Shares issued to Citadel pursuant to warrant agreement

7,932,412

2

20

305

3,152

 Placing on 14 Dec 2011

6,000,000

2

14

258

2,650

Less share issue costs

-

-

(16,303)

 As at 31 December 2011

310,616,862

1,118

38,601

Placing on 25 Sept 2012

6,000,000

2

15

59

601

Less share issue costs

(3)

(31)

 As at 31 December 2012

316,616,862

1,133

39,171

As at 30 June 2013

316,616,862

1,133

39,171

 Total shares in issue

316,616,862

 

 

 

The substantial shareholders have not changed from 31 December 2012.The Group has one class of ordinary shares which carry no right to fixed income.

 

 

3. Employee Benefit Trust

 

In accordance with the requirements of SIC 12 "Consolidation-special purpose entities" and IAS 32 "Financial Instruments: Presentation", certain of the assets and liabilities of the EBT have been included in the company's and Group's accounts resulting in the inclusion of RMB 21,000 own shares and RMB 5,832,000 share premium. This represents shares held by the Employee Benefit Trust that had not vested to employees.

 

On 24 March 2011,the shareholders approved the establishment of the China New Energy Limited Employee Benefit Trust (the "EBT") and the associated share scheme as part of the company's employee incentive arrangements. The scheme provided for the issue of up to 8,079,728 shares to employees in respect of the one year ended 23 May 2012 for nil consideration.

 

Income statement change

 

 

Unaudited

Unaudited

Audited

Six months to 30 June

Six months to 30 June

Year to 31 December

2013

2012

2012

RMB'000

RMB'000

RMB'000

Original scheme

 

 

 2,207

 

2,207 

 

 

 

 2,207

 

2,207 

 

As required by SIC 12-"Consolidation - Special Purpose Entities" and IAS 32 the EBT is included in the company's and Group's accounts, accordingly this shareholding of 8,079,728 ordinary shares is represented in the Statement of Changes In Equity as Own Shares (RMB 5,853,000).

 

 

4. Earnings per share

 

Earnings per share ("EPS") on a basic and diluted basis are as follows:

 

Earnings

Weighted average number of shares

Earning per shares

Earnings

Weighted average number of shares

Earning per shares

Six months

Six months

Six months

Six months

Six months

Six months

to 30 June

to 30 June

to 30 June

to 30 June

to 30 June

to 30 June

2013

2013

2013

2012

2012

2012

Unaudited

Unaudited

Unaudited

Unaudited

Unaudited

Unaudited

RMB'000

RMB'000

RMB'000

RMB'000

RMB'000

RMB'000

Earnings/(loss)per share-basic

(3,097)

316,616,862

(0.0097)

(6,038)

316,616,862

(0.019)

Potentially dilutive shares

-

-

-

-

-

Earnings/(loss)per share-diluted

(3,097)

316,616,862

(0.0097)

(6,038)

316,616,862

(0.019)

 

 

5. Directors' interests

 

The following Directors have held office during the period and their interests as at 30June 2013, all of which are beneficial unless otherwise stated, whether direct or indirect, of the Directors and their families in the issued share capital of the company and options over Ordinary Shares which had been granted, are as follows:

 

Director

Number of Ordinary Shares

Percentage of Ordinary Shares

Yu Weijun

 90,932,440

28.72%

Tang Zhaoxing

48,000,000

15.16%

Chen Yong

-

-

Richard Bennett

-

-

 

6. Business Segment

 

The CNE Group's assets, liabilities and capital expenditure are almost entirely attributable to a single business segment of provision of technology and engineering services to ethanol, ethanol downstream product and biobutanol producers. Therefore, the CNE Group does not have separately reportable business segments under IFRS 8 Segmental Reporting. Nonetheless the CNE Group's revenue and results can be classified into the following streams:

 

a. EPC of plants producing ethanol and ethanol downstream products ("EPC activities"); and

b. Value-added and other value added services ("VAS") services.

Revenue

EPC

VAS

Total

RMB'000

RMB'000

RMB'000

Unaudited six months to 30 Jun 2013

16,141

4,017

20,158

Unaudited six months to 30 Jun 2012

40,976

7,717

48,693

Year ended 31 Dec 2012

144,450

1,704

146,151

Results

Unaudited six months to 30 Jun 2013

2,090

574

2,664

Unaudited six months to 30 Jun 2012

6,219

84

6,303

Year ended 31 Dec 2012

26,759

782

25,977

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR PGUQABUPWGGM
Date   Source Headline
14th Jul 20206:00 pmRNSChina New Energy
14th Jul 20204:49 pmRNSHKEx Admission and Cancellation of Trading on AIM
14th Jul 20202:05 pmRNSSecond Price Monitoring Extn
14th Jul 20202:00 pmRNSPrice Monitoring Extension
14th Jul 202011:06 amRNSSecond Price Monitoring Extn
14th Jul 202011:00 amRNSPrice Monitoring Extension
14th Jul 20207:00 amRNSGlobal Offering, Issue of Equity and HKEx update
30th Jun 20207:00 amRNSPublication of Prospectus and Global Offering
29th Jun 20204:40 pmRNSSecond Price Monitoring Extn
29th Jun 20204:35 pmRNSPrice Monitoring Extension
23rd Jun 20207:00 amRNSHong Kong Listing Update
8th Jun 202011:05 amRNSSecond Price Monitoring Extn
8th Jun 202011:00 amRNSPrice Monitoring Extension
30th Apr 20201:08 pmRNSConvertible Loan Extension
16th Apr 202010:31 amRNSResult of AGM
30th Mar 202011:56 amRNSResubmission of Hong Kong Listing Application
26th Mar 20201:53 pmRNSPosting of Circular and Notice of AGM
26th Mar 202012:56 pmRNSFinal Results
11th Feb 20207:00 amRNSTrading Update and Coronavirus Information
4th Feb 20202:05 pmRNSSecond Price Monitoring Extn
4th Feb 20202:00 pmRNSPrice Monitoring Extension
8th Jan 20207:00 amRNSHong Kong Listing Update
24th Oct 20198:36 amRNSDirector/PDMR Shareholding
23rd Oct 201910:35 amRNSResult of EGM
15th Oct 20192:05 pmRNSSecond Price Monitoring Extn
15th Oct 20192:00 pmRNSPrice Monitoring Extension
7th Oct 20197:00 amRNSDirector/PDMR Shareholding
3rd Oct 20194:35 pmRNSPrice Monitoring Extension
2nd Oct 20193:28 pmRNSPosting of Circular and Notice of EGM
27th Sep 20193:45 pmRNSHalf-year Report
5th Sep 20192:05 pmRNSSecond Price Monitoring Extn
5th Sep 20192:00 pmRNSPrice Monitoring Extension
3rd Sep 20194:41 pmRNSSecond Price Monitoring Extn
3rd Sep 20194:36 pmRNSPrice Monitoring Extension
29th Jul 201910:13 amRNSResult of AGM
26th Jul 20192:11 pmRNSDirector/PDMR Shareholding
23rd Jul 20194:11 pmRNSHolding(s) in Company
23rd Jul 20193:31 pmRNSHolding(s) in Company
22nd Jul 201911:20 amRNSDirector/PDMR Shareholding
28th Jun 20198:31 amRNSNotice of AGM
25th Jun 20197:00 amRNSUpdate re Listing
19th Jun 20195:59 pmRNSFinal Results
16th Apr 20197:00 amRNSDirector/PDMR Shareholding
15th Mar 20197:00 amRNSDirector's Dealing
21st Feb 20197:00 amRNSAppointment of Broker
8th Feb 20199:05 amRNSSecond Price Monitoring Extn
8th Feb 20199:00 amRNSPrice Monitoring Extension
4th Feb 20197:00 amRNSConvertible Loan Agreement
17th Dec 20184:39 pmRNSTrading Update
24th Sep 20187:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.